Drug
CKD732 clinical trials
Also written ZGN-440, Beloranib and ZGN-433.
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 0
Zafgen, Inc. (8)
Related medicines
As reviewed, each with the page that says it.
- One of Angiogenesis Inhibitors source
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses CKD732 is read from its arms, and is right about nine times in ten.
Testing it · 8
- Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi SyndromeTerminatedPhase 3Zafgen, Inc.NCT02179151Written as ZGN-440 for Injectable Suspension
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic InjuryCompletedPhase 2Zafgen, Inc.NCT02063295Written as ZGN-440 sterile diluent
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi SyndromeCompletedPhase 2Zafgen, Inc.NCT01818921Written as ZGN-440 sterile diluent
- An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese SubjectsCompletedPhase 2Zafgen, Inc.NCT01666691Written as Beloranib
- An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes MellitusTerminatedPhase 2Zafgen, Inc.NCT02324491Written as ZGN-440 for Injectable Suspension
- ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of ObesityCompletedPhase 1Zafgen, Inc.NCT01507077Written as ZGN-440
- Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female VolunteersCompletedPhase 1Zafgen, Inc.NCT01028261Written as ZGN-433
- Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female VolunteersCompletedPhase 1Zafgen, Inc.NCT01372761Written as ZGN-433
Codes
What other systems call CKD732 · ClinicalTrials.gg INT004672
- MeSH (NLM) C487952CKD732Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) FI471K8BU6BELORANIBConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C487952 | CKD732 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | FI471K8BU6 | BELORANIB | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.